4.7 Article

Celecoxib:Nicotinamide dissociation:: Using excipients to capture the cocrystal's potential

Journal

MOLECULAR PHARMACEUTICS
Volume 4, Issue 3, Pages 386-400

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/mp0700108

Keywords

polymorphs; pharmaceutical; cocrystal; nicotinamide; morphology; dissolution; stability; celecoxib; formulation

Ask authors/readers for more resources

The cocrystal of celecoxib and nicotinamide ( Cel: Nic) was crystallized from chloroform in a 1: 1 ratio, and the structure has been solved from powder X- ray diffraction data. The dissolution and solubility of Cel: Nic are medium dependent and can be attributed to differences in conversion of Cel: Nic to celecoxib polymorphs I and III (Cel- I and CeI-III). The presence of low concentrations of surfactants facilitates the rapid conversion of neat Cel: Nic to large aggregates of Cel- III that dissolve more slowly than commercial Cel- III into 1% SDS solution. In contrast, combinations of CeI: Nic with both 1-10% solid SDS and PVP wet rapidly and convert to a mixture of amorphous celecoxib and a micron-sized crystalline celecoxib form IV (CeI- IV), which has recently been shown to be up to 4-fold more bioavailable than marketed CeI-III. More than 90% of the suspended material dissolves within 2 min at 37 degrees C when transferred to 1% SDS solution. This example highlights the importance of exploring the form conversion of cocrystals in aqueous media prior to pharmacokinetic studies, and illustrates the potential of simple formulations to overcome the limitations caused by rapid dissociation of cocrystals and recrystallization of poorly soluble forms in aqueous media.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available